tiprankstipranks
Pharming Group price target raised to EUR 1.90 from EUR 1.80 at RBC Capital
PremiumThe FlyPharming Group price target raised to EUR 1.90 from EUR 1.80 at RBC Capital
9M ago
Pharming enrolls first patient in leniolisib trial in Japan
PremiumThe Fly
Pharming enrolls first patient in leniolisib trial in Japan
9M ago
Pharming nominates Richard Peters to become chairman
PremiumThe Fly
Pharming nominates Richard Peters to become chairman
10M ago
Pharming initiated with an Outperform at RBC Capital
PremiumThe FlyPharming initiated with an Outperform at RBC Capital
1y ago
Pharming price target raised to $40 from $36 at Oppenheimer
PremiumThe Fly
Pharming price target raised to $40 from $36 at Oppenheimer
1y ago
Pharming up 22% after resuming trading following announcement of FDA approval
PremiumThe Fly
Pharming up 22% after resuming trading following announcement of FDA approval
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100